Joe Zuerker
Gastroenterology · Oklahoma City, OKNPI 1780693309
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.8% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $978 and has fallen 98.0% since, to $20 in 2023. That places this record below the midpoint for gastroenterology clinicians in OK, where the typical reported total is $4,832.
Across 143 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$471
- AbbVie$446
- Takeda Pharmaceuticals U.S.A., Inc.$295
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$182
- Braintree Laboratories, Inc.$125
- Puma Biotechnology, Inc.$106
- plus $782 from 22 others
What the payments were for
- Food & beverage$2,25994%
- Education$422%
- Gifts$1074%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 33 | $471 |
| AbbVie | 29 | $446 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $295 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $182 |
| Braintree Laboratories, Inc. | 3 | $125 |
| Puma Biotechnology, Inc. | 2 | $106 |
| Redhill Biopharma Inc. | 4 | $68 |
| Novartis | 4 | $66 |
| Nestle Healthcare Nutrition Inc. | 3 | $64 |
| AstraZeneca | 4 | $59 |
| Intercept Pharmaceuticals, Inc. | 4 | $56 |
| Merck | 4 | $53 |
| Eisai Inc. | 3 | $51 |
| Seagen Inc. | 3 | $47 |
| Sanofi | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| QOL Medical, LLC | 2 | $30 |
| Boston Scientific | 2 | $30 |
| Ironwood Pharmaceuticals, Inc | 2 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Abbott | 1 | $21 |
| Incyte Corporation | 1 | $19 |
| Amgen | 1 | $18 |
| Foundation Medicine, Inc. | 1 | $17 |
| Rigel Pharmaceuticals, Inc. | 1 | $16 |
| Bristol Myers Squibb | 1 | $15 |
| Covidien LP | 1 | $14 |
| G1 Therapeutics, Inc. | 1 | $14 |
How this compares
$2,407 in reported general payments places this provider in the 40th percentile of 133 gastroenterology providers in Oklahoma.
Other gastroenterology in Oklahoma City
- George SalemOklahoma City$1.2M
- Tauseef AliOklahoma City$536K
- Pooja SinghalOklahoma City$140K
- Hussein BitarOklahoma City$120K
- Trushar PatelOklahoma City$49K
- Matthew McBrideOklahoma City$33K
- Sanjay SikkaOklahoma City$31K
- Tony TranOklahoma City$11K
- Ahmad Al-TaeeOklahoma City$11K
- Sumit WaliaOklahoma City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.